Diagnostic Neuropathology 2021

This section of the website is currently for diagnostic neuropathology trainees who start specialty training from August 2021.

Diagnostic Neuropathology Curriculum 2021

The new 2021 curricula will be assessed by High Level Outcomes, which are included in the form of Capabilities in Practice (CiPs), CiPs describe the professional tasks or work within the scope of postgraduate pathology training; they are based on the format of entrustable professional activities, which are a method of using the professional judgement of appropriately trained assessors as a key aspect of the validity of assessment and a defensible way of forming global judgements of professional performance.

Diagnostic Neuropathology Syllabus

This syllabus is an adjunct to the curriculum and is to guide aspects of learning expected to be covered during diagnostic neuropathology training.

Independent Reporting

Assessment Strategy

The Royal College of Pathologists' assessment strategy identifies the broad approach and purpose of our programme of assessment and describes the approach for the medical pathology specialties regulated by the General Medical Council.

Workplace based assessments

Trainees will be expected to undertake Supervised Learning Events (SLEs) throughout their speicalty training. Further information on the SLEs and assessment programme can be found in the 2021 curriculum.

ARCP Decision Aid

The ARCP decision aid will be avaliable shortly.

Cellular Pathology Curricula Launch Event

A virtual curricula launch event was held with the aim to introduce the new cellular pathology curricula to trainers and educational supervisors and to understand Capabilities in Practice and how they will inform assessment of trainees.

Attendee were able to ask questions throughout the webinar. Below are the questions that were asked and answered during event.

Questions and answers


Why the extra time for diagnostic neuropathology?

CiP 9. It is almost the opposite of the proforma reporting and the dataset reporting practice - how are the clinical educational supervisors expected to manager this dichotomy?

Is AOP every month, quarterly, half yearly, yearly or is it after every specialist attachment?

What is the guidance around the research module? Has the changed from the previous curriculum?

Is there anything in the new curriculum regarding molecular training?

For less than full-time trainees who are due an ARPC before spring 2022 will the move to the new curriculum be after their ARCP or wait to spring 2022

What will the numbers for stage D look like if stage D training is going to be 6 months? Half of these numbers?

Is the new curriculum published on the website?

How would go about addressing the lack of post-mortem practice in a centre?

Is there any scope for subspecialty training in the curriculum?

Is there any guidance on cervical cytology training which is now not reporting in our region making it difficult for trainees to access?

How does digital reporting sit with the curriculum? Digital reporting is not permitted for all cases and there is a defined validation process.

Is the timings for recruitment to paediatrics, forensic and neuropathology going to be changed to take into account the extra 6 months in ICPT?

Have you thought how trainees may achieve dual accreditation and re-enter the training programme? This raises the issue how to recognise existing competencies and adapting the CCT times.

Some specialist centres have complex cases hence fewer numbers, what is your advice regarding these.

Is there scope for a trainee to remain in training for more than 6 months post part 2?


How would the Educational Supervisors and Training Programme Directors access the New LEPT system?


Will the FRCPath Part 2 be reviewed as well?

Is there any change to when each exam can be first attempted?